Showing 1–20 of 61 results
Cystic Fibrosis Leukopak
LeukoCore™ Cystic Fibrosis Leukopak products contain concentrated immune cells from donors with clinically confirmed Cystic Fibrosis, collected via apheresis. Ideal for high-yield studies on Cystic Fibrosis-related immune cell profiling, cell-based assays, and gene expression profiling.
Cystic Fibrosis PBMC
Cystic Fibrosis PBMC samples are collected from clinically confirmed Cystic Fibrosis donors and cryopreserved for downstream immunology and cell-based assays. Ideal for studying inflammatory pathways, immune cell responses, and therapeutic development in Cystic Fibrosis.
Cystic Fibrosis Plasma
Cystic Fibrosis Plasma – Cryopreserved human cycstic fibrosis plasma collected from clinically confirmed cystic fibrosis donors. Cystic Fibrosis plasma is ideal for inflammation studies, cytokine profiling, and biomarker research.
Cystic Fibrosis Serum
Cystic Fibrosis Serum – Human cystic fibrosis serum samples collected from clinically confirmed donors. Ideal for immunology, cytokine profiling, and inflammation-related research.
Cystic Fibrosis Whole Blood
Fresh Cystic Fibrosis Whole Blood – IRB-consented cystic fibrosis whole blood samples collected from clinically diagnosed donors. Ideal for systemic biomarkers and omics research.
Down Syndrome PBMC
Down Syndrome PBMC samples are isolated from donors with clinically and genetically confirmed Down syndrome (trisomy 21). Ideal for studying immune dysregulation, T cell function, and chronic inflammation associated with chromosomal imbalance.
Down Syndrome Plasma
Down Syndrome Plasma samples are collected from donors diagnosed with Down syndrome. Suitable for profiling cytokines, metabolic markers, and proteins linked to accelerated aging and comorbidities such as Alzheimer’s disease.
Down Syndrome Serum
Down Syndrome Serum samples are derived from donors with confirmed Down syndrome (trisomy 21). Useful for analyzing inflammatory markers, hormone levels, and biomarkers associated with immune and endocrine dysfunction.
Down Syndrome Whole Blood
Down Syndrome Whole Blood samples are obtained from donors with clinically diagnosed Down syndrome. Valuable for transcriptomic studies, immune cell phenotyping, and exploring gene expression patterns Influenzaenced by trisomy 21.
Fabry Disease Plasma
Fabry Disease Plasma – Cryopreserved human plasma collected from clinically confirmed Fabry Disease donors. Fabry Disease plasma is ideal for metabolic biomarkers for understanding disease progression.
Fabry Disease Serum
Fabry Disease Serum – Human serum samples collected from clinically confirmed Fabry Disease donors. Ideal for measuring changes in biomarkers and treatment response.
Fabry Disease Whole Blood
Fabry Disease Whole Blood – IRB-consented whole blood samples collected from donors diagnosed with Fabry Disease. Ideal for dermatology, immunology, and inflammation-based research.
Facioscapulohumeral Muscular Dystrophy PBMC
Facioscapulohumeral Muscular Dystrophy PBMC samples are isolated from donors with genetically confirmed facioscapulohumeral muscular dystrophy (FSHD). Ideal for investigating immune involvement in muscle degeneration, inflammation-related pathways, and potential therapeutic targets in dystrophic muscle disease.
Facioscapulohumeral Muscular Dystrophy Plasma
Facioscapulohumeral Muscular Dystrophy Plasma samples are collected from donors diagnosed with facioscapulohumeral muscular dystrophy (FSHD). Suitable for analyzing muscle damage biomarkers, proinflammatory cytokines, and circulating proteins linked to disease activity and progression.
Facioscapulohumeral Muscular Dystrophy Serum
Facioscapulohumeral Muscular Dystrophy Serum samples are derived from donors with confirmed facioscapulohumeral muscular dystrophy (FSHD). Useful for measuring creatine kinase levels, immune mediators, and markers of muscle injury and systemic inflammation.
Facioscapulohumeral Muscular Dystrophy Whole Blood
Facioscapulohumeral Muscular Dystrophy Whole Blood samples are obtained from donors with clinically and genetically diagnosed facioscapulohumeral muscular dystrophy (FSHD). Valuable for transcriptomic studies, immune cell profiling, and identifying gene expression patterns associated with DUX4 activation and muscular dystrophy pathology.
Friedreich’s Ataxia PBMC
Friedreich’s Ataxia PBMC samples are isolated from donors with genetically confirmed Friedreich’s ataxia. Ideal for studying mitochondrial dysfunction, oxidative stress responses, and immune involvement in neurodegenerative disease.
Friedreich’s Ataxia Plasma
Friedreich’s Ataxia Plasma samples are collected from donors diagnosed with Friedreich’s Ataxia. Suitable for analyzing metabolic abnormalities, markers of oxidative damage, and circulating proteins linked to mitochondrial impairment and disease progression.
Friedreich’s Ataxia Serum
Friedreich’s Ataxia Serum samples are derived from donors with confirmed Friedreich’s Ataxia. Useful for evaluating frataxin-related biomarkers, inflammatory markers, and systemic indicators of neurodegeneration and cardiomyopathy.
Friedreich’s Ataxia Whole Blood
Friedreich’s Ataxia Whole Blood samples are obtained from donors with genetically diagnosedFriedreich’s Ataxia. Valuable for gene expression studies, mitochondrial DNA analysis, and immune cell profiling in hereditary ataxia research.